Switzerland Life Science Trend Analysis 2023

Although shifts in the geopolitical landscape affected the Swiss life sciences industry in 2022, it resisted a major downturn in terms of private equity funding. Swiss biotech companies raised a total of USD 590 million in venture capital in 36 financing rounds. This is less than in the previous three years, but matches pre-COVID 19 … Continue reading Switzerland Life Science Trend Analysis 2023

Read more

Switzerland Life Science Trend Analysis 2022

As Biotechgate data shows, private equity investment rounds of life science companies increased by around 35% in 2021 compared to 2020. Despite venture investments in biotech companies declining slightly in 2021 compared to the strong previous annum, it was still a solid year for the biotech industry in Switzerland. Four of the five biotech companies … Continue reading Switzerland Life Science Trend Analysis 2022

Read more

Switzerland Life Science Market Trend Analysis 2021

We are proud to present the annual life science market trend report for Switzerland that was compiled in cooperation with our partners: the Swiss Biotech Association, Basel Area Business & Innovation, Life Science Zurich, Canton of Zurich, and the City of Zurich. The report shows the thriving nature of the Swiss biotech industry that proved … Continue reading Switzerland Life Science Market Trend Analysis 2021

Read more

Swiss Life Science Market Trend Analysis 2020

Our annual Swiss market trend analysis compiled with Biotechgate data shows that the life science industry in Switzerland is thriving. The amount of money raised in venture financing rounds in 2019 was nearly twice as large as in 2018. Also, more new biotech companies were launched last year than two years ago.

Read more

Swiss Life Sciences Trend Analysis 2019

2018 was another very active year in the Swiss life sciences industry. The report compiled using the data from Biotechgate shows that the biotech financing was only slightly lower than in the record in 2017, while the total value of investments for the whole life science industry was even higher than in the previous year. … Continue reading Swiss Life Sciences Trend Analysis 2019

Read more

Swiss Life Sciences Trend Analysis 2018

2017 did not bring a lot of new life science companies to Switzerland. However, the total value of the venture financing of existing companies was twice as high as it was in 2016 with over 600 million USD invested. The largest amount went to ADC Therapeutics Inc and will be used to progress their products … Continue reading Swiss Life Sciences Trend Analysis 2018

Read more

Swiss Life Science Trend Analysis 2017

Our annual trend report for the Swiss life sciences market proves that Switzerland remains one of the most important locations in the life science industry. In 2016, Swiss biotechnology companies attracted funding worth nearly 400 million USD in total.  Switzerland LS Trend Analysis 2017 Looking for your next Biotech or Medtech partner? Use Biotechgate to … Continue reading Swiss Life Science Trend Analysis 2017

Read more

Swiss Life Sciences Trend Analysis 2016

Our latest trend analysis of the Swiss biotechnology and life sciences sector shows that despite a slow start to the year, investment in the area rose substantially in the second half of 2015. However the decline in the amount of new biotech companies being founded has continued. In fact last year had the lowest number of … Continue reading Swiss Life Sciences Trend Analysis 2016

Read more

Swiss Life Sciences Trend Analysis 2015

In comparison to the previous year, the amount of financing for the life science companies decreased by almost 37% in 2014. In contrast to this, the amount of products in development increased in the first half of 2015 which indicates a continuous growth of the industry. Click here to download Swiss Life Sciences Trend Analysis … Continue reading Swiss Life Sciences Trend Analysis 2015

Read more

Swiss Life Sciences Trend Analysis 2014

While the number of Swiss Biotech companies in 2013 remained close to its 2012 levels, the total financing value amassed within the sector more than doubled compared to last year’s figure, reaching USD 325m (112% increase). Click here to download Swiss Life Sciences Trend Analysis 2014 – 14 pages Looking for your next Biotech or … Continue reading Swiss Life Sciences Trend Analysis 2014

Read more